"When we first met with our partner, a clinician at a renowned Children’s Hospital, he and his team were ready to publish the results of their whole-genome gene expression study. We presented them with a viable solution to advance the validation of their gene signature – something they originally thought would be too expensive and time consuming with other available technologies. As a result of our work together, they gained a deeper understanding of their signature as a potential diagnostic test, and, along with other collaborators, they learned much more about the biology of the disease. Our partner told us 'it was worth the wait.'"